Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
Clinical trial NCT06552234 · RECRUITING
Trial details
- NCT number
- NCT06552234
- Sponsor
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2031-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.